McCormack C - Search Results

1

van der Weyden C, McCormack C, Lade S, Johnstone RW, Prince HM. van der Weyden C, et al. Among authors: mccormack c. Cancer Treat Res. 2019;176:195-224. doi: 10.1007/978-3-319-99716-2_10. Cancer Treat Res. 2019. PMID: 30596220

2

Pegylated liposomal doxorubicin in the treatment of cutaneous T-cell lymphoma.

Prince HM, Seymour JF, Ryan G, McCormack C. Prince HM, et al. Among authors: mccormack c. J Am Acad Dermatol. 2001 Jan;44(1):149-50. doi: 10.1067/mjd.2001.109857. J Am Acad Dermatol. 2001. PMID: 11148501 No abstract available.

3

Bexarotene capsules and gel for previously treated patients with cutaneous T-cell lymphoma: results of the Australian patients treated on phase II trials.

Prince HM, McCormack C, Ryan G, Baker C, Rotstein H, Davison J, Yocum R. Prince HM, et al. Among authors: mccormack c. Australas J Dermatol. 2001 May;42(2):91-7. doi: 10.1046/j.1440-0960.2001.00488.x. Australas J Dermatol. 2001. PMID: 11309029 Clinical Trial.

4

Primary cutaneous B-cell lymphomas.

Prince HM, Yap LM, Blum R, McCormack C. Prince HM, et al. Among authors: mccormack c. Clin Exp Dermatol. 2003 Jan;28(1):8-12. doi: 10.1046/j.1365-2230.2003.01170.x. Clin Exp Dermatol. 2003. PMID: 12558619 Review.

5

Treatment of patients with advanced mycosis fungoides and Sézary syndrome with alemtuzumab.

Kennedy GA, Seymour JF, Wolf M, Januszewicz H, Davison J, McCormack C, Ryan G, Prince HM. Kennedy GA, et al. Among authors: mccormack c. Eur J Haematol. 2003 Oct;71(4):250-6. doi: 10.1034/j.1600-0609.2003.00143.x. Eur J Haematol. 2003. PMID: 12950233 Clinical Trial.

6

Graft-versus-lymphoma effect in refractory cutaneous T-cell lymphoma after reduced-intensity HLA-matched sibling allogeneic stem cell transplantation.

Herbert KE, Spencer A, Grigg A, Ryan G, McCormack C, Prince HM. Herbert KE, et al. Among authors: mccormack c. Bone Marrow Transplant. 2004 Sep;34(6):521-5. doi: 10.1038/sj.bmt.1704641. Bone Marrow Transplant. 2004. PMID: 15286686 Review.

7

Long-term clearance of patch-stage mycosis fungoides with the 308-nm laser.

Upjohn E, Foley P, Lane P, Magee J, Prince HM, McCormack C, Sinclair R. Upjohn E, et al. Among authors: mccormack c. Clin Exp Dermatol. 2007 Mar;32(2):168-71. doi: 10.1111/j.1365-2230.2006.02308.x. Epub 2006 Nov 27. Clin Exp Dermatol. 2007. PMID: 17137475

8

Rituximab in the adjuvant treatment of pemphigus vulgaris: a prospective open-label pilot study in five patients.

Goh MS, McCormack C, Dinh HV, Welsh B, Foley P, Prince HM. Goh MS, et al. Among authors: mccormack c. Br J Dermatol. 2007 May;156(5):990-6. doi: 10.1111/j.1365-2133.2007.07800.x. Epub 2007 Mar 13. Br J Dermatol. 2007. PMID: 17355229

9

Successful treatment of Behçet's disease with lenalidomide.

Green J, Upjohn E, McCormack C, Zeldis J, Prince HM. Green J, et al. Among authors: mccormack c. Br J Dermatol. 2008 Jan;158(1):197-8. doi: 10.1111/j.1365-2133.2007.08288.x. Epub 2007 Nov 6. Br J Dermatol. 2008. PMID: 17986298 No abstract available.

10

Diagnosis and Management of Hereditary Basal Cell Skin Cancer.

Shanley S, McCormack C. Shanley S, et al. Among authors: mccormack c. Recent Results Cancer Res. 2016;205:191-212. doi: 10.1007/978-3-319-29998-3_11. Recent Results Cancer Res. 2016. PMID: 27075355

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

320 results

Search Page

Filters